Imepip
Nazivi | |
---|---|
IUPAC naziv 4-(3H-imidazol-4-ilmethil)piperidin | |
Identifikacija | |
| |
3D model (Jmol) |
|
IUPHAR/BPS |
|
PubChem[1][2] C ID |
|
SMILES
| |
Svojstva | |
C9H15N3 | |
Molarna masa | 165,2355 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Y verifikuj (šta je YН ?) | |
Reference infokutije | |
Imepip je histaminski agonist koji je specifičan za histaminski H3 receptor.[3]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Cannon KE, Leurs R, Hough LB (2007). „Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively”. Pharmacol. Biochem. Behav. 88 (1): 122—9. PMC 2064035 . PMID 17719621. doi:10.1016/j.pbb.2007.07.014.
Spoljašnje veze
- p
- r
- u
Histaminergici
VMAT |
---|
HDC | |
---|---|
HNMT | |
DAO | Inhibitori: Aminoguanidin |
Endogeni | Histamin; Prekursori: L-Histidin; Kofaktori: Vitamin B6 |
---|